Asia Pacific

Above photo: Suci Arumsari, President Director of Alodokter. 

Indonesia’s Alodokter successfully raises Series C extension funding
The company currently boasts over 27 million monthly active users.
Malaysia’s HealthMetrics scores $5M in Series A funding

Credit: NUS

NUS spin-off company develops one-minute breath test to detect COVID-19
Learn on-demand, earn credit, find products and solutions. Get Started >>

Regional News

Health2Sync partners with DAIKYO ASTAGE & two pharmacies to pilot health management services in Japan
November 25, 2020
TCM company Eu Yan Sang to provide online consultations thru partnership with MyDoc
November 19, 2020
Combining Fitbit wearable devices & glucose control app leads to better diabetes management: Health2Sync Clinical Study
November 13, 2020
KT signs MoU with Sibel Health to expand its digital health capabilities
November 12, 2020
Holmusk & Merck partner to improve treatment outcomes for prediabetes & diabetes patients in APAC
November 11, 2020
Hospitech Respiration starts joint venture with AwakeZone to expand reach in China
November 10, 2020
Omron, HeartVoice & Great Eastern launch new program to encourage healthy living
October 29, 2020
Savonix launches Japanese website as part of international expansion
October 26, 2020

More Regional News

Global News

More Global News
Coronavirus vaccine
Blockchain could be the key to vaccine distribution, says IBM
By Laura Lovett
November 25, 2020
With these funds, Well Health has now raised $75 million since its founding in 2015.
Well Health pulls in $45M and welcomes a new senior vice president
By Mallory Hackett
November 25, 2020
Supply chain gaps, lack of standards exposed by COVID-19
By HIMSS TV
November 25, 2020

Special Projects

Building a Solid Foundation for Transformation
Focusing on privacy and security in the coronavirus new normal
Nurse in mask using a computer.
Population health management enters an uncharted new era
Population illustration
How stakeholders are separating the hype from the real deal
Digital health developments in 2020 and beyond: What to expect
Focus on: The Future of Pharma